124 related articles for article (PubMed ID: 25196737)
1. Site-selective labeling of a lysine residue in human serum albumin.
Asano S; Patterson JT; Gaj T; Barbas CF
Angew Chem Int Ed Engl; 2014 Oct; 53(44):11783-6. PubMed ID: 25196737
[TBL] [Abstract][Full Text] [Related]
2. Human Serum Albumin Domain I Fusion Protein for Antibody Conjugation.
Patterson JT; Wilson HD; Asano S; Nilchan N; Fuller RP; Roush WR; Rader C; Barbas CF
Bioconjug Chem; 2016 Oct; 27(10):2271-2275. PubMed ID: 27666414
[TBL] [Abstract][Full Text] [Related]
3. Site-Specific Albumin-Selective Ligation to Human Serum Albumin under Physiological Conditions.
Yu X; Ruan M; Wang Y; Nguyen A; Xiao W; Ajena Y; Solano LN; Liu R; Lam KS
Bioconjug Chem; 2022 Dec; 33(12):2332-2340. PubMed ID: 36350013
[TBL] [Abstract][Full Text] [Related]
4. Chemical reactivity of ethyl (6R)-6-[N-(2-chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242) in vitro.
Jinno F; Yoneyama T; Morohashi A; Kondo T; Asahi S
Biopharm Drug Dispos; 2011 Oct; 32(7):408-25. PubMed ID: 21887787
[TBL] [Abstract][Full Text] [Related]
5. Enhanced therapeutic potential of antibody fragment via IEDDA-mediated site-specific albumin conjugation.
Go EB; Lee JH; Cho JH; Kwon NH; Choi JI; Kwon I
J Biol Eng; 2024 Apr; 18(1):23. PubMed ID: 38576037
[TBL] [Abstract][Full Text] [Related]
6. Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.
Jansen RW; Schols D; Pauwels R; De Clercq E; Meijer DK
Mol Pharmacol; 1993 Nov; 44(5):1003-7. PubMed ID: 7902528
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of albumin conjugates of a truncated peptide YY analogue for half-life extension.
Ehrlich GK; Michel H; Truitt T; Riboulet W; Pop-Damkov P; Goelzer P; Hainzl D; Qureshi F; Lueckel B; Danho W; Conde-Knape K; Konkar A
Bioconjug Chem; 2013 Dec; 24(12):2015-24. PubMed ID: 24251972
[TBL] [Abstract][Full Text] [Related]
8. Development of a neuromedin U-human serum albumin conjugate as a long-acting candidate for the treatment of obesity and diabetes. Comparison with the PEGylated peptide.
Neuner P; Peier AM; Talamo F; Ingallinella P; Lahm A; Barbato G; Di Marco A; Desai K; Zytko K; Qian Y; Du X; Ricci D; Monteagudo E; Laufer R; Pocai A; Bianchi E; Marsh DJ; Pessi A
J Pept Sci; 2014 Jan; 20(1):7-19. PubMed ID: 24222478
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and characterization of protein and polylysine conjugates of sulfamethoxazole and sulfanilic acid for investigation of sulfonamide drug allergy.
Tatake JG; Knapp MM; Ressler C
Bioconjug Chem; 1991; 2(2):124-32. PubMed ID: 1868114
[TBL] [Abstract][Full Text] [Related]
10. Biotin/Folate-decorated Human Serum Albumin Nanoparticles of Docetaxel: Comparison of Chemically Conjugated Nanostructures and Physically Loaded Nanoparticles for Targeting of Breast Cancer.
Nateghian N; Goodarzi N; Amini M; Atyabi F; Khorramizadeh MR; Dinarvand R
Chem Biol Drug Des; 2016 Jan; 87(1):69-82. PubMed ID: 26216713
[TBL] [Abstract][Full Text] [Related]
11. Site-Specific Albumination as an Alternative to PEGylation for the Enhanced Serum Half-Life in Vivo.
Yang B; Lim SI; Kim JC; Tae G; Kwon I
Biomacromolecules; 2016 May; 17(5):1811-7. PubMed ID: 27050863
[TBL] [Abstract][Full Text] [Related]
12. Effect of C-terminus Conjugation via Different Conjugation Chemistries on In Vivo Activity of Albumin-Conjugated Recombinant GLP-1.
Park J; Bak M; Min K; Kim HW; Cho JH; Tae G; Kwon I
Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33672039
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and physicochemical characteristics of a liver-targeted conjugate of fluorodeoxyuridine monophosphate with lactosaminated human albumin.
Di Stefano G; Tubaro M; Lanza M; Boga C; Fiume L; Traldi P
Rapid Commun Mass Spectrom; 2003; 17(22):2503-7. PubMed ID: 14608620
[TBL] [Abstract][Full Text] [Related]
14. Stereoselective esterase activity of human serum albumin toward ketoprofen glucuronide.
Dubois-Presle N; Lapicque F; Maurice MH; Fournel-Gigleux S; Magdalou J; Abiteboul M; Siest G; Netter P
Mol Pharmacol; 1995 Mar; 47(3):647-53. PubMed ID: 7700262
[TBL] [Abstract][Full Text] [Related]
15. The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. III. Human serum albumin-methotrexate derivative, its preparation and basic testing.
Bures L; Bostík J; Motycka K; Spundová M; Rehák L
Neoplasma; 1988; 35(3):329-42. PubMed ID: 3405341
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of human serum albumin-modified exendin-4 conjugate via heterobifunctional polyethylene glycol linkage with protracted hypoglycemic efficacy.
Kim I; Kim TH; Ma K; Lee ES; Kim D; Oh KT; Lee DH; Lee KC; Youn YS
Bioconjug Chem; 2010 Aug; 21(8):1513-9. PubMed ID: 20715855
[TBL] [Abstract][Full Text] [Related]
17. Chemical Modification of Cysteine with 3-Arylpropriolonitrile Improves the In Vivo Stability of Albumin-Conjugated Urate Oxidase Therapeutic Protein.
Yang B; Kwon I
Biomedicines; 2021 Sep; 9(10):. PubMed ID: 34680451
[TBL] [Abstract][Full Text] [Related]
18. Characterization of adducts formed between human serum albumin and the butadiene metabolite epoxybutanediol.
Lindh CH; Kristiansson MH; Berg-Andersson UA; Cohen AS
Rapid Commun Mass Spectrom; 2005; 19(18):2488-96. PubMed ID: 16106353
[TBL] [Abstract][Full Text] [Related]
19. Characterization of glycation adducts on human serum albumin by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Wa C; Cerny RL; Clarke WA; Hage DS
Clin Chim Acta; 2007 Oct; 385(1-2):48-60. PubMed ID: 17707360
[TBL] [Abstract][Full Text] [Related]
20.
Vantourout JC; Mason AM; Yuen J; Simpson GL; Evindar G; Kuai L; Hobbs M; Edgar E; Needle S; Bai X; Wilson S; Scott-Stevens P; Traylen W; Lambert K; Young N; Bunally S; Summerfield SG; Snell R; Lad R; Shi E; Skinner S; Shewchuk L; Watson AJB; Chung CW; Pal S; Holt DA; Kallander LS; Prendergast J; Rivera K; Washburn DG; Harpel MR; Arico-Muendel C; Isidro-Llobet A
Bioconjug Chem; 2021 Feb; 32(2):279-289. PubMed ID: 33523652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
